These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5696082)

  • 21. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antigenicity of inactivated swine influenza virus concentrated by centrifugation.
    Woods GT; Mansfield ME
    Res Commun Chem Pathol Pharmacol; 1976 Jan; 13(1):129-32. PubMed ID: 1257594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 to 9 December 2011.
    Ampofo WK; Al Busaidy S; Cox NJ; Giovanni M; Hay A; Huang S; Inglis S; Katz J; Mokhtari-Azad T; Peiris M; Savy V; Sawanpanyalert P; Venter M; Waddell AL; Wickramasinghe G; Zhang W; Ziegler T;
    Vaccine; 2013 Jul; 31(32):3209-21. PubMed ID: 23685246
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity of egg-grown influenza vaccine: inhibition by immunization of recipients with host antigen.
    Lindenmann J
    Infect Immun; 1972 Jun; 5(6):883-9. PubMed ID: 4635503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The occurrence of human influenza virus antibodies in the sera of certain wild species of animal. Brief report.
    Shortridge KF; Belyavin G; Bidwell DE
    Arch Gesamte Virusforsch; 1970; 32(2):286-90. PubMed ID: 4322845
    [No Abstract]   [Full Text] [Related]  

  • 26. Antigenicity of influenza vaccine from bovine cell cultures.
    Leiderman E; Mogabgab WJ
    Appl Microbiol; 1969 Oct; 18(4):596-600. PubMed ID: 4905036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nature of the immunity evoked by infection of mice with avirulent influenza virus.
    Kurimura T; Hirano A; Okuno Y
    Biken J; 1972 Mar; 15(1):31-7. PubMed ID: 5055346
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.
    Schulman JL; Kilbourne ED
    J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS
    Bull World Health Organ; 1969; 41(3):525-30. PubMed ID: 5309467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunizing effect of different cleavage products from influenza viruses].
    Lange FC
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):390-1. PubMed ID: 5523686
    [No Abstract]   [Full Text] [Related]  

  • 31. The significance of influenza virus neuraminidase in immunity.
    Rott R; Becht H; Orlich M
    J Gen Virol; 1974 Jan; 22(1):35-41. PubMed ID: 4855928
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody response obtained by vaccination with the influenza A-Equi 2 virus in man.
    Masurel N
    Nature; 1968 Apr; 218(5136):100-1. PubMed ID: 5643539
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative immunogenicity-reactogenicity dose-response study of influenza vaccine.
    Guarnaccia S; Peters SM; Habib F; Mancuso GR; Dibenedetto SP; Espey M; Bellanti JA
    Ann Allergy; 1990 Sep; 65(3):218-21. PubMed ID: 2403227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preventive influenza vaccination--possibilities and limits in the prevention of influenza-virus infections].
    Wesselius-de Casparis A
    Med Monatsschr; 1973 Oct; 27(10):447-9. PubMed ID: 4777787
    [No Abstract]   [Full Text] [Related]  

  • 37. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
    Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
    Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of antibody in the canine tracheal pouch after local and systemic influenza immunization.
    Lieberman P; Berlin BS; Metzger J; Patterson R
    J Immunol; 1972 Oct; 109(4):864-9. PubMed ID: 5074334
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibody response to an anti-influenza vaccine of inactivated whole virus, titrated in micrograms, used in the 1980/81 season].
    Mancini G; Sarrecchia C; Donatelli I; Santoro A; Arangio-Ruiz G; Andreoni M; Rozera C; Sordillo P; Rocchi G
    Boll Ist Sieroter Milan; 1982 May; 61(2):92-6. PubMed ID: 7126343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.